• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Members of the Drug Shortages Task Force

 

Center for Drug Evaluation and Research

Office of the Center Director
Douglas C. Throckmorton, MD, Deputy Director for Regulatory Programs

Drug Shortages Staff
CAPT Valerie Jensen, R.Ph., Associate Director
CAPT Jouhayna Saliba, Pharm.D., Team Leader
CDR Emily Thakur, R.Ph., Team Leader

Office of Regulatory Policy
Kalah Auchincloss, JD, MPH, Regulatory Counsel
Michael Bernstein, JD, Director, Division of Regulatory Policy II

Office of Compliance
Ilisa B.G. Bernstein, Pharm.D., JD, Deputy Director for Program Operations
Catherine Gould, Pharm.D., Team Leader, Recalls and Shortages Branch
Douglas Stearn, JD, Deputy Director for Policy and Analysis

Office of Pharmaceutical Science
Emanuela Lacana, PhD, Team Leader, Office of Biotechnology Products
Norman R. Schmuff, Associate Director for Product Quality, Office of New Drug Quality Assessment

Office of Strategic Programs
Russell Wesdyk, Scientific Coordinator
Marta Wosinska, PhD, Director, Economics Staff

Office of Generic Drugs
CAPT Harvey Greenberg, R.Ph., Drug Shortage Coordinator

Office of Executive Programs
Kristin Phucas, Regulatory Health Project Manager
 

Center for Biologics Evaluation and Research

Office of the Center Director
Diane Maloney, JD, Associate Director for Policy

Office of Compliance and Biologics Quality
Joseph P. Manik, Special Assistant for Imports and Product Availability
Anita Richardson, MAS, Associate Director for Policy
 

Office of Regulatory Affairs

Office of Medical Products and Tobacco Operations
Colleen F. Hoyt, Branch Chief, Team Biologics